-transparent.png){kind=logo}
Hyporeninemic hypoaldosteronism was diagnosed in a young woman with glomerulonephritis who was receiving indomethacin therapy. Despite only mildly abnormal renal function, serum K+ was elevated to 6.2 meq/L, and plasma renin activity (0.12 ng/mL h) and aldosterone (4.4 ng/dL) failed to respond to the combined stimuli of furosemide and posture. Urinary prostaglandin E2 (PGE2) was suppressed (70 ng/24 h). When indomethacin was withdrawn, significant kaliuresis occurred, accompanied by normalization of serum K+ and PGE2 and a supranormal rebound in renin and aldosterone levels. Challenge with indomethacin resulted in antikaliuresis and resuppression of PGE2, renin, and aldosterone. This case study documents for the first time that indomethacin can cause the syndrome of hyporeninemic hypoaldosteronism, probably by inhibiting prostaglandin biosynthesis.
S Y Tan, and
R Shapiro, and
R Franco, and
H Stockard, and
P J Mulrow
January 1981,
Archives of internal medicine,
S Y Tan, and
R Shapiro, and
R Franco, and
H Stockard, and
P J Mulrow
January 1980,
Kidney international,
S Y Tan, and
R Shapiro, and
R Franco, and
H Stockard, and
P J Mulrow
September 1979,
Annals of internal medicine,
S Y Tan, and
R Shapiro, and
R Franco, and
H Stockard, and
P J Mulrow
September 1979,
Annals of internal medicine,
S Y Tan, and
R Shapiro, and
R Franco, and
H Stockard, and
P J Mulrow
May 2009,
Kidney international,
S Y Tan, and
R Shapiro, and
R Franco, and
H Stockard, and
P J Mulrow
May 1980,
Klinicheskaia meditsina,
S Y Tan, and
R Shapiro, and
R Franco, and
H Stockard, and
P J Mulrow
April 1994,
Journal of Korean medical science,
S Y Tan, and
R Shapiro, and
R Franco, and
H Stockard, and
P J Mulrow
February 1989,
Endocrinologia japonica,
S Y Tan, and
R Shapiro, and
R Franco, and
H Stockard, and
P J Mulrow
January 1979,
Urologiia i nefrologiia,
S Y Tan, and
R Shapiro, and
R Franco, and
H Stockard, and
P J Mulrow
December 1982,
Schweizerische medizinische Wochenschrift,
